1 Great Reason to Buy Moderna (and It Has Nothing to Do With the COVID Vaccine)

Why buy Moderna (NASDAQ: MRNA) stock? Many people will point to the company's coronavirus vaccine. The product is the reason for this biotech company's meteoric rise to stardom, after all. Moderna grabbed investors' attention as the pandemic gained ground last spring: It was the first to launch a clinical trial for a vaccine candidate. And it sealed the deal at the end of the year, when it became one of the first to commercialize a vaccine.

Today, the vaccine is generating billions of dollars in revenue, and it even made Moderna profitable after just one full quarter of sales. So it might seem obvious that the vaccine is a good reason to buy Moderna shares -- it is.

But there's another solid reason to invest in this biotech company. And it, too, may represent billions of dollars down the road.

Source Fool.com